Zituvio Tablet
Product Images NDC 70710-1240

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvio (NDC 70710-1240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D2e68080 F67c 462b A330 45012873d719 01)

Chemical structure of Sitagliptin, the active ingredient in ZITUVIO tablets. The diagram shows the molecular composition including functional groups and fluorine atoms represented by F.*

FDA Label Image

Image (D2e68080 F67c 462b A330 45012873d719 02)

A line graph showing LS mean change from baseline over 24 weeks among different treatment groups: placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, Sitagliptin 50 mg twice daily with Metformin 500 mg twice daily, and Sitagliptin 50 mg twice daily with Metformin 1000 mg twice daily.*

FDA Label Image

Image (D2e68080 F67c 462b A330 45012873d719 03)

A line graph depicting least squares mean change from baseline over a 52-week period. The x-axis represents time in weeks from 0 to 52, and the y-axis shows the least squares mean change from baseline, ranging approximately from 0.0 to -1.5. Two data series are shown with diamond and circle markers, displaying a decrease in mean change initially, stabilizing between weeks 12 and 30, and then a gradual increase towards week 52.*

FDA Label Image

25 mg Label (D2e68080 F67c 462b A330 45012873d719 04)

Zituvio (sitagliptin) Tablets 25 mg film-coated tablets label by Zydus Pharmaceuticals (USA) Inc. The label indicates a package size of 90 tablets with prescription use only. It includes dosage information, storage instructions, and warnings to dispense the enclosed Medication Guide and to use tablets within 3 months of opening. The NDC code 70710-1240-9 and manufacturer details are displayed.*

FDA Label Image

50 mg Label (D2e68080 F67c 462b A330 45012873d719 05)

Label for ZITUVIO 50 mg film-coated tablets containing the active ingredient sitagliptin. The oral tablet packaging shows the NDC 70710-1241-9, a 90-tablet count, and includes usage, storage, and dispensing instructions. The labeler is Zydus Pharmaceuticals (USA) Inc. with manufacturing by Zydus Lifesciences Ltd., Ahmedabad, India.*

FDA Label Image

100 mg Label (D2e68080 F67c 462b A330 45012873d719 06)

Zituvio (sitagliptin) Tablets 100 mg oral tablets packaging label from Zydus Pharmaceuticals (USA) Inc. The label indicates 90 tablets in the package with prescription-only status. It includes dosage information and storage instructions, emphasizing dispensing in the original container and use within 3 months of opening. Manufacturer and distributor details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.